Stay updated with breaking news from Chong Kun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Chong Kun Dang (CKD) Kochon Foundation has awarded Ukraine health authorities for their medical effforts to treat tuberculosis during the ongoing war with Russia, the Korean pharmaceutical company said Sunday.
Chong Kun Dang (CKD) is accelerating the development of new drugs by significantly expanding investments in research and development, the pharmaceutical company said Sunday. During the first five months of this year, CKD spent 181.4 billion won ($141.7 million) or 12.2 percent of its annual sales in 2022 to expand the scope of new drug development to advanced biopharmaceuticals and antibody drug conjugates (ADC) such as gene and cell therapies. The pharmaceutical company is expected to focus on first-in-class drugs and responding to unmet needs in the medical market.
Even as the COVID-19 pandemic shook up the world, the IP landscape in the Asian region remained buoyant thanks to its agility and digital readiness. This was reflected in the best law firms for IP work, which went above and beyond when it came to servicing their clients in difficult times.
Even as the COVID-19 pandemic shook up the world, the IP landscape in the Asian region remained buoyant thanks to its agility and digital readiness. This was reflected in the best law firms for IP work, which went above and beyond when it came to servicing their clients in difficult times.